- Home
- ARDX vs GHRS Comparison
ARDX vs GHRS Comparison
Compare ARDX & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- GHRS
- Stock Information
- Founded
- ARDX 2007
- GHRS 2018
- Country
- ARDX United States
- GHRS Ireland
- Employees
- ARDX N/A
- GHRS N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- ARDX Health Care
- GHRS Health Care
- Exchange
- ARDX Nasdaq
- GHRS Nasdaq
- Market Cap
- ARDX 885.2M
- GHRS 849.8M
- IPO Year
- ARDX 2014
- GHRS 2021
- Fundamental
- Price
- ARDX $3.93
- GHRS $12.66
- Analyst Decision
- ARDX Strong Buy
- GHRS Strong Buy
- Analyst Count
- ARDX 9
- GHRS 8
- Target Price
- ARDX $10.17
- GHRS $30.63
- AVG Volume (30 Days)
- ARDX 4.6M
- GHRS 186.6K
- Earning Date
- ARDX 07-31-2025
- GHRS 05-08-2025
- Dividend Yield
- ARDX N/A
- GHRS N/A
- EPS Growth
- ARDX N/A
- GHRS N/A
- EPS
- ARDX N/A
- GHRS N/A
- Revenue
- ARDX $361,706,000.00
- GHRS N/A
- Revenue This Year
- ARDX $12.01
- GHRS N/A
- Revenue Next Year
- ARDX $34.66
- GHRS N/A
- P/E Ratio
- ARDX N/A
- GHRS N/A
- Revenue Growth
- ARDX 127.33
- GHRS N/A
- 52 Week Low
- ARDX $3.21
- GHRS $6.00
- 52 Week High
- ARDX $8.06
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- ARDX 57.99
- GHRS 49.08
- Support Level
- ARDX $3.49
- GHRS $11.50
- Resistance Level
- ARDX $3.72
- GHRS $12.54
- Average True Range (ATR)
- ARDX 0.16
- GHRS 0.83
- MACD
- ARDX 0.06
- GHRS -0.12
- Stochastic Oscillator
- ARDX 98.21
- GHRS 17.09
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.